1.
Trends Biotechnol
; 31(6): 329-32, 2013 Jun.
Article
in English
| MEDLINE
| ID: mdl-23427900
ABSTRACT
Bioremediation differs from other industrial biotechnologies in that, although bioremediation contractors must profit from the activity, the primary driver is regulatory compliance rather than manufacturing profit. It is an attractive technology in the context of a bioeconomy but currently has limitations at the field scale. Ecogenomics techniques may address some of these limitations, but a further challenge would be acceptance of these techniques by regulators.